165 related articles for article (PubMed ID: 31313694)
1. Adnexotropism as a Histopathological Clue for the Diagnosis of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
Pérez González YC; Llamas Velasco MDM; Díaz Recuero JL; Machan S; Núñez Hipolito L; Piris Pinilla MA; Rodríguez Pinilla SM
Am J Dermatopathol; 2020 May; 42(5):383-384. PubMed ID: 31313694
[No Abstract] [Full Text] [Related]
2. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
3. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
Bakr F; Wain EM; Wong S; Palmer R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
Yi LG; Gru AA
Am J Dermatopathol; 2021 Dec; 43(12):e293-e297. PubMed ID: 34001748
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.
Keeling BH; Gavino ACP; Admirand J; Soldano AC
J Cutan Pathol; 2017 Nov; 44(11):944-947. PubMed ID: 28749588
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound Appearance of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
Rodríguez-Lomba E; Molina-López I; Pulido-Pérez A; Ciudad-Blanco C
Actas Dermosifiliogr; 2017 Oct; 108(8):792-794. PubMed ID: 28388988
[No Abstract] [Full Text] [Related]
7. Primary Cutaneous CD4
Maurelli M; Colato C; Gisondi P; Girolomoni G
J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
Sarac E; Demirkesen C
An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
[No Abstract] [Full Text] [Related]
9. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
Salah E
J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
[TBL] [Abstract][Full Text] [Related]
11. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Valentim FO; Oliveira CC; Miot HA
An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
[TBL] [Abstract][Full Text] [Related]
13. Eccrine gland stroma changes in cutaneous hamartoma of infancy.
Fernandez M; Al-Hammadi A; Nahal A
J Cutan Pathol; 2008 May; 35(5):508-9. PubMed ID: 18399811
[No Abstract] [Full Text] [Related]
14. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
[TBL] [Abstract][Full Text] [Related]
16. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification.
Kempf W; Kazakov DV; Cozzio A; Kamarashev J; Kerl K; Plaza T; Metze D
Am J Dermatopathol; 2013 Apr; 35(2):159-66. PubMed ID: 22885550
[TBL] [Abstract][Full Text] [Related]
18. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic validation of capillary electrophoresis analysis of T-cell receptor gamma-chain gene rearrangements: prediction of malignant transformation of cutaneous T-cell lymphoproliferative disorders.
Chang TL; Salto-Tellez M; Thamboo TP; Lee YS; Koay ES
Clin Chem; 2003 Mar; 49(3):513-5. PubMed ID: 12600972
[No Abstract] [Full Text] [Related]
20. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment.
Gru AA; Wick MR; Eid M
Semin Cutan Med Surg; 2018 Mar; 37(1):39-48. PubMed ID: 29719019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
